[1] Frequent Recovery of HIV-1 From Genital Herpes Simplex Virus Lesions in HIV-1–Infected Men

[2] rancang bangun aplikasi antivirus komputer dengan menggunakan metode secure hash algorithm 1 (sha1) dan heuristic string

[3] reação de inibição da hemaglutinação para o vírus da rubéola: técnica simplificada rubella hemagglutination-inhibition test: a simplified technique

[4] In-field capable loop-mediated isothermal amplification detection of Turnip yellows virus in plants and its principal aphid vector Myzus persicae.

[5] Immobilization of gold nanoparticles with rhodamine to enhance the fluorescence resonance energy transfer between quantum dots and rhodamine; new method for downstream sensing of infectious bursal disease virus

[6] Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada.

[7] Shared Molecular Signatures Across Neurodegenerative Diseases and Herpes Virus Infections Highlights Potential Mechanisms for Maladaptive Innate Immune Responses.

[8] Reverse transcription recombinase polymerase amplification assay for rapid detection of canine associated rabies virus in Africa.

[9] Delivery of antisense peptide nucleic acid by gold nanoparticles for the inhibition of virus replication.

[10] Gold nanoparticles and hepatitis B virus

[11] Yield parameters and antioxidant compounds of tomato fruit: the role of plant defence inducers with or without Cucumber mosaic virus infection.

[12] Prognostic profile of patients with non-viral hepatocellular carcinoma: A comparative study with hepatitis C virus-related hepatocellular carcinoma using data mining analysis.

[13] Genomic characterization of mumps viruses from a large-scale mumps outbreak in Arkansas, 2016.

[14] Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

[15] Activation of the autophagy pathway by Torovirus infection is irrelevant for virus replication.

[16] Quantitative proteomics identify an association between extracellular matrix degradation and immunopathology of genotype VII Newcastle disease virus in the spleen in chickens.

[17] Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies – a comprehensive review

[18] Cost-effectiveness of direct anti-viral agents for hepatitis C virus infection and a combined intervention of syringe access and medication assisted therapy for opioid use disorders in an injection drug use population.

[19] A model to study the inhibition of nsP2B-nsP3 protease of dengue virus with imidazole, oxazole, triazole thiadiazole, and thiazolidine based scaffolds.

[20] Plasmonic Nanomaterial-Based Optical Biosensing Platforms for Virus Detection

[21] Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach.

[22] A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

[23] Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

[24] Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

[25] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[26] Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study

[27] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[28] Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt

[29] Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

[30] Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

[31] Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

[32] Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

[33] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

[34] Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

[35] Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

[36] Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

[37] Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

[38] Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China

[39] Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

[40] Drug resistance in influenza A virus: the epidemiology and management

[41] Concern over Zika virus outbreak: another alarming global threat

[42] Influence of host resistance on viral adaptation: hepatitis C virus as a case study

[43] New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

[44] Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

[45] Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

[46] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[47] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[48] Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

[49] Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

[50] Zika virus challenges for neuropsychiatry

[51] A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

[52] Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

[53] Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

[54] A high prevalence of human T-lymphotropic virus (HTLV 1/2) infection among Afro-descendants, Esmeraldas province, Ecuador – need for the implementation of surveys and control programs

[55] Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies

[56] Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience [Corrigendum]

[57] Immunoinformatics Approach for Multiepitopes Vaccine Prediction against Glycoprotein B of Avian Infectious Laryngotracheitis Virus

[58] Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia

[59] Molecular Characterization of African Swine Fever Viruses from Outbreaks in Peri-Urban Kampala, Uganda

[60] Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase

[61] Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth

[62] A Rare Case of Herpes Simplex Virus-2 Hepatitis with Negative Serology

[63] Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

[64] Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study

[65] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[66] Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt

[67] Epidemiological and molecular analysis of avian influenza A(H7N9) virus in Shanghai, China, 2013–2017

[68] Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

[69] Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant

[70] Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents

[71] Antiviral resistance markers in influenza virus sequences in Mexico, 2000–2017

[72] Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapse

[73] Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience

[74] Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection

[75] Right and left ventricular function in hospitalized children with respiratory syncytial virus infection

[76] Prevalence of hepatitis C virus-resistant association substitutions to direct-acting antiviral agents in treatment-naïve hepatitis C genotype 1b-infected patients in western China

[77] Detection of hepatitis C virus (HCV) among health care providers in an Egyptian university hospital: different diagnostic modalities

[78] Drug resistance in influenza A virus: the epidemiology and management

[79] Concern over Zika virus outbreak: another alarming global threat

[80] Influence of host resistance on viral adaptation: hepatitis C virus as a case study

[81] New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents

[82] Application of Optimal Control Theory to Newcastle Disease Dynamics in Village Chicken by Considering Wild Birds as Reservoir of Disease Virus

[83] Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

[84] Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

[85] Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

[86] Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

[87] Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

[88] Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

[89] Antibodies against Schmallenberg virus detected in cattle in the Otjozondjupa region, Namibia

[90] Zika virus challenges for neuropsychiatry

[91] Genotypic characterisation of Avian paramyxovirus type-1 viruses isolated from aquatic birds in Uganda

[92] Genetic characterisation of African swine fever virus from 2017 outbreaks in Zambia: Identification of p72 genotype II variants in domestic pigs

[93] Immunogenicity of a plasmid DNA vaccine encoding G1 epitope of bovine ephemeral fever virus G glycoprotein in mice

[94] Peste des petits ruminants virus infection of Black Bengal goats showed altered haematological and serum biochemical profiles

[95] Peste des petits ruminants in Africa: Meta-analysis of the virus isolation in molecular epidemiology studies

[96] Development of a Colloidal Gold Kit for the Diagnosis of Severe Fever with Thrombocytopenia Syndrome Virus Infection

[97] Illumina sequencing of clinical samples for virus detection in a public health laboratory

[98] Combination therapy targeting platelet activation and virus replication protects mice against lethal influenza pneumonia.

[99] Analytical performances of the BD Veritor™ System for the detection of respiratory syncytial virus and influenzaviruses A and B when used at bedside in the pediatric emergency department.

[100] Development of a reverse transcription recombinase polymerase amplification assay for rapid detection of human respiratory syncytial virus.

[101] Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient